Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazine

Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazine

Introduction: Patients with coronary microvascular dysfunction (CMD) are at increased risk of developing heart failure with preserved ejection fraction (HFpEF). We hypothesized that higher myocardial biomarkers (ultra-high sensitivity cardiac troponin I [u-hs-TnI]) and ventricular dysfunction (N-ter...

Full description

Saved in:
Bibliographic Details
Main Authors: Katherine E. Hampilos, Anum Asif, Puja K. Mehta, Daniel S. Berman, Galen Cook-Wiens, Michael D. Nelson, Carl J. Pepine, C. Noel Bairey Merz, Janet Wei
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:American Heart Journal Plus
Subjects:
Coronary microvascular dysfunction
Ischemia and no obstructive coronary artery disease
Ranolazine
Myocardial perfusion reserve index
N-terminal pro-BNP
Ultra-high sensitivity cardiac troponin I
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602225000163
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666602225000163

Similar Items